Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan G Howlett

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
The Canadian Journal of Cardiology|April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Sean Virani, Michael Chan, et al.
The New England Journal of Medicine|September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.
The Canadian Journal of Cardiology|February 11, 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O'Meara, Michael McDonald, Michael Chan, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The Canadian Journal of Cardiology|May 21, 2010
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapyDaniel G Hackam, Nadia A Khan, Brenda R Hemmelgarn, et al.
The Canadian Journal of Cardiology|August 2, 2011
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapyDoreen M Rabi, Stella S Daskalopoulou, Raj S Padwal, et al.
The Canadian Journal of Cardiology|May 19, 2012
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapyStella S Daskalopoulou, Nadia A Khan, Robert R Quinn, et al.
The Canadian Journal of Cardiology|April 2, 2013
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionDaniel G Hackam, Robert R Quinn, Pietro Ravani, et al.
The Canadian Journal of Cardiology|May 5, 2015
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionStella S Daskalopoulou, Doreen M Rabi, Kelly B Zarnke, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
The Canadian Journal of Cardiology|April 8, 2021
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionMichael McDonald, Sean Virani, Michael Chan, et al.
The New England Journal of Medicine|September 20, 2019
Dapagliflozin in Patients with Heart Failure and Reduced Ejection FractionJohn J V McMurray, Scott D Solomon, Silvio E Inzucchi, et al.
The Canadian Journal of Cardiology|February 11, 2020
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in AmyloidosisEileen O'Meara, Michael McDonald, Michael Chan, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The Canadian Journal of Cardiology|May 21, 2010
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapyDaniel G Hackam, Nadia A Khan, Brenda R Hemmelgarn, et al.
The Canadian Journal of Cardiology|August 2, 2011
The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapyDoreen M Rabi, Stella S Daskalopoulou, Raj S Padwal, et al.
The Canadian Journal of Cardiology|May 19, 2012
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapyStella S Daskalopoulou, Nadia A Khan, Robert R Quinn, et al.
The Canadian Journal of Cardiology|April 2, 2013
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionDaniel G Hackam, Robert R Quinn, Pietro Ravani, et al.
The Canadian Journal of Cardiology|May 5, 2015
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertensionStella S Daskalopoulou, Doreen M Rabi, Kelly B Zarnke, et al.
Pageof 13